Every month we send an email newsletter to our supporters sharing recent updates from our work. We publish selected portions of the newsletter on our blog to make this news more accessible to people who visit our website. For key updates from the latest installment, please see below!
If you’d like to receive the complete newsletter in your inbox each month, you can subscribe here.
Working Toward $2.5 Billion in Malaria Grantmaking
GiveWell aims to direct at least $2.5 billion in new malaria funding from 2027 through 2032. This builds on GiveWell’s growth over the past five years as we’ve expanded the scale of our team and grantmaking. This year, we expect to direct more than $1 billion in donor funding across all areas, more than double the amount we directed last year.
Malaria control has long been a central focus of our work—in total, GiveWell has directed more than $1.3 billion to malaria prevention and treatment to date. Malaria kills around 600,000 people each year, most of whom are young children. There are known ways to prevent, diagnose, and treat the disease, but many people in countries where malaria is endemic don’t have access to these resources, and recent declines in health aid have widened existing funding gaps.
Our expanded support could go to current grantees as well as new organizations and novel funding vehicles. We’re in the process of assessing which strategies for deploying new malaria funding are likely to be highly cost-effective and scalable. One strategy we’re exploring is the Malaria Impact Accelerator—a partnership with the Global Fund to help rapidly scale our impact across many programs in many countries at once.
We’re also growing our grantmaking in other areas. We expect to direct more than $1 billion outside malaria in 2027. While the scale of our grantmaking is growing, we remain focused on researching the most cost‑effective ways to save and improve lives, sharing our work openly, and directing donations to help people in need as much as we can.
On our blog, we share more about our growing malaria grantmaking—including what and how much we might fund, how long we’ll fund programs, the components of the Malaria Impact Accelerator, and more.
Behind the Research: How Our Team Tackles Hard Questions
As GiveWell works to direct substantially more funding, our research is expanding in two directions: going broader, to cover more areas of global health and development, and going deeper, to improve the inputs that inform our decision-making.
In our recent podcast episode, GiveWell co-founder and CEO Elie Hassenfeld speaks with three researchers about how this expansion is playing out in their work. They each describe a project they’ve taken on: reassessing how to prevent childhood pneumonia deaths, building a better estimate of how many children die of malaria, and developing an AI tool to check our work for errors.
Grant Spotlight
Our grantmaking aims to support programs that save or improve lives the most per dollar. Here’s a look at one recent example:
What: Implementation and evaluation of an electronic system for tracking health supply stock levels
Where: Five provinces in Laos
Who: Clinton Health Access Initiative (CHAI) and the mSupply Foundation
Total: Approximately $3.8 million
How it works: Many health systems in low- and middle-income countries track stocks of medicines and supplies with paper registers, which makes it harder to reorder in time and can lead to expired medicines and stockouts. This grant will fund CHAI and the mSupply Foundation to implement an electronic stock-tracking system in local health clinics across five provinces in Laos, and to evaluate its effectiveness through a randomized controlled trial (RCT).
Why this grant: While many countries have begun using electronic stock-tracking systems, there is limited evidence on whether they reduce stockouts or help patients get the treatment they need. We believe this will be the first RCT of these systems in local health clinics, and the first study to attempt to determine whether fewer stockouts lead to more patients receiving treatment. Based on the trial results, we may consider funding the program more widely.
Funded by: Donations to GiveWell’s Unrestricted Fund
To learn more, read the grant page.
Hiring Announcements
We’re continuing to grow our team and have several open positions. If you or someone you know might be a good fit, please apply or share the relevant link below.
- Senior Recruiter, Research
- Senior Communications Officer, Editorial & Production
- Senior Communications Officer, Media & Public Affairs
- Senior Philanthropy Advisor
- Senior Program Officers
- Senior Researchers (subteam-specific roles available)
Visit our Jobs page to see all open positions.
Partner Roundup
- Hear how digital registration changed Malaria Consortium’s seasonal malaria chemoprevention program in Nampula, Mozambique, where we’ve supported the program since 2020.
- Learn how an update to New Incentives’ program lets caregivers recover transportation support they missed on vaccination visits when no field officer was present.
- Read an interview with Helen Keller Intl’s vitamin A program lead about how its program reaches millions of children across Africa each year.
Comments or Questions?
We’re always looking for fresh perspectives on our research. If you have comments or questions about our work, we want to hear from you! Reach out to us at info@givewell.org.